Trial Profile
Drug Use Investigation of Kovaltry in Hemophilia A Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2023
Price :
$35
*
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions
- Sponsors Bayer
- 13 Jan 2023 Planned End Date changed from 31 Mar 2023 to 27 Mar 2024.
- 18 May 2022 Status changed from recruiting to active, no longer recruiting.
- 05 Jul 2021 Planned End Date changed from 30 Sep 2022 to 31 Mar 2023.